Hyperglycemia elevates the Risk of Stent Restenosis in STEMI Patients MD Bureau27 Nov 2021 9:15 AM ISTST-elevation myocardial infarction (STEMI) is one of the leading causes of death and hospitalization worldwide. Acute hyperglycemia is common in...
No difference in all cause death in PCI and CABG in left main CAD After 5-Years: LANCET MD Bureau16 Nov 2021 8:30 PM ISTPercutaneous coronary intervention (PCI) involving drug-eluting stents is increasingly used to treat complex coronary artery disease, although...
Quantitative flow ratio guided PCI significantly improves outcomes in CAD patients: Lancet Dr Kartikeya Kohli6 Nov 2021 11:15 AM ISTA novel technique, Quantitative flow ratio uses 3D artery reconstruction and measurement of blood flow velocity that gives precise measurements...
Prasugrel superior to ticagrelor for ACS patients who underwent PCI: JAMA MD Editorial Team19 Oct 2021 9:00 AM ISTGermany: A prespecified subgroup analysis of a randomized clinical trial revealed that among patients with acute coronary syndrome (ACS) who underwent...
Same-day discharge after elective PCI not associated with bad outcomes: Study Dr. Shravani Dali16 Oct 2021 10:47 PM ISTSame-day discharge after elective Percutaneous Coronary Intervention (PCI) not associated with bad outcomes, suggests a study published in the JACC: ...
Marijuana use tied to higher risk of bleeding, VV accidents after PCI: JACC Study MD Editorial Team21 Sept 2021 9:00 AM ISTUSA: Marijuana usage is linked with increased risks of cerebrovascular accident and hemorrhage and a reduced risk of acute renal damage following...
Intracoronary hypothermia safe in primary PCI reveal early results of EURO-ICE trial dr. Abhimanyu Uppal15 Sept 2021 9:45 AM ISTReperfusion injury may undermine a considerable part of the recovery of the ischemic myocardium achieved by Primary PCI (percutaneous intervention)....
Ticagrelor monotherapy reduces bleeding risk in patients undergoing PCI with and without CKD: Study Dr. Shravani Dali8 Sept 2021 9:30 AM ISTAccording to a study published in the European Heart Journal ticagrelor monotherapy reduces significant bleeding without significantly increasing ...
No apparent benefit of Multivessel PCI among older STEMI patients: Study Dr. Shravani Dali31 Aug 2021 9:00 AM ISTMultivessel percutaneous coronary intervention (MV PCI) is not much beneficial for all older patients with ST-segment–elevation myocardial...
Revacept doesn't reduce myocardial injury risk in patients undergoing PCI: JAMA Medha Baranwal22 July 2021 9:00 AM ISTGermany: The addition of revacept to standard antithrombotic therapy in patients with stable ischemic heart disease (SIHD) undergoing PCI, does not...
Clopidogrel superior to aspirin in reducing adverse events after PCI with DES: Lancet Medha Baranwal9 July 2021 10:45 AM ISTClopidogrel monotherapy reduced long-term rates of all-cause mortality, non-fatal myocardial infarction, and stroke after drug-eluting stent placement...
Periprocedural myocardial injury and MI associated with PCI- Consensus document Medha Baranwal16 Jun 2021 10:30 AM ISTDelhi: The ESC Working Group on Cellular Biology of the Heart and European Association of Percutaneous Cardiovascular Interventions (EAPCI) has...
